0001140361-23-050569.txt : 20231031
0001140361-23-050569.hdr.sgml : 20231031
20231031215640
ACCESSION NUMBER: 0001140361-23-050569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231027
FILED AS OF DATE: 20231031
DATE AS OF CHANGE: 20231031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GNI Group Ltd.
CENTRAL INDEX KEY: 0001958461
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 231366365
BUSINESS ADDRESS:
STREET 1: NIHONBASHI-HONCHO YS BLDG 3F
STREET 2: 2-2-2 NIHONBASHI-HONCHO, CHUO-KU
CITY: TOKYO
STATE: M0
ZIP: 103-0023
BUSINESS PHONE: 81-3-6214-3600
MAIL ADDRESS:
STREET 1: NIHONBASHI-HONCHO YS BLDG 3F
STREET 2: 2-2-2 NIHONBASHI-HONCHO, CHUO-KU
CITY: TOKYO
STATE: M0
ZIP: 103-0023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GNI USA, Inc.
CENTRAL INDEX KEY: 0001973229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 231366364
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-284-0324
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 650-266-8674
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
form4.xml
X0508
4
2023-10-27
0001124105
GYRE THERAPEUTICS, INC.
GYRE
0001958461
GNI Group Ltd.
NIHONBASHI-HONCHO YS BLDG 3F
2-2-2 NIHONBASHI-HONCHO, CHUO-KU
TOKYO
M0
103-0023
JAPAN
true
0001973229
GNI USA, Inc.
12730 HIGH BLUFF DRIVE
SUITE 250
SAN DIEGO
CA
92130
true
false
Series X Convertible Preferred Stock
2023-10-27
4
P
0
811
4915
A
Common Stock
811000
13151
I
See Footnote
Series X Convertible Preferred Stock Warrant (Right to Buy)
2023-10-27
4
P
0
8110300
0.125
A
2023-10-30
2033-10-30
Series X Convertible Preferred Stock
811
8110300
I
See Footnote
Shares of Series X Convertible Preferred Stock of the Issuer, par value $0.001 per share (the "Preferred Stock"), are convertible into shares of the Issuer's common stock at any time at the option of the holder thereof, based on the Conversion Ratio and subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for the Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on December 27, 2022).
The Preferred Stock has no expiration date.
These securities are held by GNI USA, Inc., a Delaware corporation ("GNI USA") which is a wholly-owned subsidiary of GNI Group Ltd., a company incorporated under the laws of Japan with limited liability ("GNI Japan"). GNI Japan may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the securities held by GNI USA.
These warrants have an exercise price of $4,915.00 per share of Preferred Stock.
/s/ Branden Berns, as attorney-in-fact for GNI Group Ltd.
2023-10-31
/s/ Branden Berns, as attorney-in-fact for GNI USA, Inc.
2023-10-31